Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: A prospective study

British Journal of Cancer

Volumn 76, Issue 7, 1997, Pages 968-974

  Tsai, J F ^a   Jeng, J E ^a   Ho, M S ^b   Chang, W Y ^a   Hsieh, M Y ^a   Lin, Z Y ^a   Tsai, J H ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Cirrhosis; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; ARTICLE; CHRONIC HEPATITIS; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; ULTRASOUND;

EID: 0030823524     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.493     Document Type: Article

References (37)

1. Alberti A, Pontisso P, Chemello L, Fattovich G, Benvegnu L, Belussi F and De Mitri MS (1995) The interaction between hepatitis B and hepatitis C virus in acute and chronic liver disease. J Hepatol 22 (suppl.): 38-41
2. Benvegnu L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cecchetto A and Alberti A (1994) Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 74: 2442-2448
3. Chen DS (1993) Natural history of chronic hepatitis B virus infection: new light on an old story. J Gastroenterol Hepatol 8: 470-475
4. Collazos J, Genolla J and Ruibal A (1992) Preliminary study of alpha-fetoprotein in nonmalignant liver disease: a clinico-biochemical evaluation. Int J Biol Markers 7: 97-102
5. Colombo M (1995) Should patients with chronic viral hepatitis be screened for hepatocellular carcinoma? Viral Hepatitis Rev 1: 67-75
6. Cox DR (1972) Regression models and life tables. J R Stat Soc 34 (Series B): 187-220
7. Curley SA, Izzo F, Gallipoli A, de Bellis M, Cremona F and Parisi V (1995) Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer. Ann Surg 222: 375-380
8. Diamantis ID, McGandy CE, Chen TJ, Liaw YF, Gudat F and Bianchi L (1994) Detection of hepatitis B and C viruses in liver tissue with hepatocellular carcinoma. J Hepatol 20: 405-409
9. Harrington DP and Fleming TR (1982) A class of rank test procedures for censored survival data. Biometrica 69: 553-566
10. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, Kimada H and Kawanishi M (1993) Multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 18: 47-53
11. Jeng JE and Tsai JF (1991) Hepatitis C virus antibody in hepatocellular carcinoma in Taiwan. J Med Virol 34: 74-77
12. Kaklamani E, Trichopoulos D, Tzonou A, Zavitsanos X, Koumantaki Y, Hatzakis A, Hsieh CC and Hatziyannis S (1991) Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 265: 1974-1976
13. Kaplan EL and Meier P (1958) Nonparametric estimation from incomplete observation. Am Stat Assoc 53: 457-458
14. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH and Alter HJ (1990) Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12: 671-675
15. Moradpour D and Wand JR (1996) Hepatic oncogenesis. In Hepatology: a Textbook of Liver Disease, 3rd edn, Zakim D and Boyer TD (eds) pp. 1490-1512. W.B. Saunders: Philadelphia
16. Paterlini P, Driss F, Nalpas B, Pisi E, Franco D, Berthelot P and Brechot C (1993) Persistence of hepatitis B and C viral genomes in primary liver cancers from HBsAg-negative patients: a study of low endemic area. Hepatology 17: 20-29
17. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J and Smith PG (1974) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 34: 585-612
18. Popper H (1988) Viral versus chemical hepatocarcinogenesis. J Hepatol 6: 229-238
19. Pugh RN, Murray-Lyon IM, Dawson JL, Peitroni MC and Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60: 646-649
20. Sherlock S and Dooley J (1997) Hepatic tumours. In Disease of the Liver and Biliary System, 10th edn, pp. 531-559. Blackwell Science: Oxford
21. Simonetti RG, Camma C, Fiorello F, Politi F, D'Amico G and Pagliaro L (1991) Hepatocellular carcinoma: a worldwide problem and the major risk factors. Dig Dis Sci 36: 962-972
22. Simonetti RG, Camma C, Fiorella F, Cottone M, Rapicetti M, Marino L, Fiorentino G, Craxia A, Ciccaglione A, Giuseppetti R, Stroffolini T and Pagliaro L (1992) Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. Ann Intern Med 116: 97-102
23. Takano S, Yokosuka O, Imazeki F, Tagawa M and Omata M (1995) Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 21: 650-655
24. Tong MJ, el-Farra NS, Reikes AR and Co RL (1995) Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332: 1463-1466
25. Tsai JF, Chang WY, Jeng JE, Ho MS, Wang LY, Hsieh MY, Chen SC, Chuang WL, Lin ZY and Tsai JH (1993) Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan. J Med Virol 41: 296-300
26. Tsai JF, Chang WY, Jeng JE, Ho MS, Lin ZY and Tsai JH (1994a) Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver 14: 98-102
27. Tsai JF, Chang WY, Jeng JE, Ho MS, Lin ZY and Tsai JH (1994b) Frequency of raised α-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C. Br J Cancer 69: 1157-1159
28. Tsai JF, Chang WY, Jeng JE, Ho MS, Lin ZY and Tsai JH (1994c) Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma. J Med Virol 44: 92-95
29. Tsai JF, Jeng JE, Ho MS, Chang WY, Lin ZY and Tsai JH (1994d) Hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Chinese: a case-control study. Int J Cancer 56: 619-621
30. Tsai JF, Jeng JE, Chang WY, Ho MS, Lin ZY and Tsai JH (1994e) Hepatitis C virus infection among patients with chronic liver disease in an area hyperendemic for hepatitis B. Scand J Gastroenterol 29: 550-552
31. Tsai JF, Jeng JE, Chang WY, Lin ZY and Tsai JH (1994f) Antibodies to hepatitis E virus among Chinese patients with acute hepatitis in Taiwan. J Med Virol 43: 341-344
32. Tsai JF, Jeng JE, Chang WY, Lin ZY and Tsai JH (1994g) Antibodies to hepatitis E and A viruses among patients with non-alcoholic chronic liver disease in Taiwan. Scand J Gastroenterol 29: 651-654
33. Tsai JF, Jeng JE, Chang WY, Ho MS, Lin ZY and Tsai JH (1995a) Increased IgM-containing circulating immune complexes in patients co-infected with hepatitis C and hepatitis B. Medicine 74: 136-143
34. Tsai JF, Jeng JE, Chang WY, Ho MS, Lin ZY and Tsai JH (1995b) Circulating immune complexes in chronic hepatitis related to hepatitis C and B viruses infection. Clin Immunol Immunopathol 75: 39-44
35. Tsai JF, Jeng JE, Ho MS, Chang WY, Hsieh MY, Lin ZY and Tsai JH (1996a) Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma. Br J Cancer 73: 1498-1502
36. Tsai JF, Jeng JE, Ho MS, Chang WY, Hsieh MY, Lin ZY and Tsai JH (1996b) Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitis. J Hepatol 24: 271-276
37. Tsai JF, Jeng JE, Ho MS, Wang CS, Chang WY, Hsieh MY, Lin ZY and Tsai JH (1997) Serum alanine aminotransferase level in relation to hepatitis B and C viruses infection among blood donors. Livers 17: 24-29